Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of December 20, 2024 • 12:00 AM ET

Date/Time Source News Release
11/12/2024 07:45 AM EST GlobeNewswire Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke
10/31/2024 07:30 AM EDT GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
09/18/2024 07:00 AM EDT GlobeNewswire Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
08/28/2024 07:00 AM EDT GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections
07/02/2024 01:58 PM EDT GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
06/12/2024 09:05 AM EDT GlobeNewswire Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
06/10/2024 07:30 AM EDT GlobeNewswire Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
04/23/2024 07:00 AM EDT GlobeNewswire Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
04/18/2024 07:00 AM EDT GlobeNewswire Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
04/02/2024 07:30 AM EDT GlobeNewswire Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
Page

Additional News

As of December 20, 2024 • 12:00 AM ET

Date/Time Source News Release
12/04/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, December 4th, 2024
12/04/2024 04:31 AM EST US Earnings Reports Expected earnings - Revive Therapeutics Ltd
11/06/2024 01:55 AM EST SeekingAlpha Massachusetts psychedelics legalization initiative poised to fail
11/04/2024 05:27 AM EST SeekingAlpha Legalizing psychedelics: Is Massachusetts next?
10/19/2024 09:40 AM EDT SeekingAlpha FDA is said to see "path forward" for ecstasy-based drug
10/16/2024 01:55 PM EDT SeekingAlpha Bright Minds rally ends as psychedelic stocks extend volatility
09/18/2024 07:09 AM EDT SeekingAlpha Revive Therapeutics to focus on Bucillamine
06/05/2024 07:17 AM EDT SeekingAlpha Psychedelic stocks fall as FDA panel rejects MDMA therapy
06/01/2024 05:38 AM EDT US Earnings Reports Expected earnings - Revive Therapeutics Ltd
05/31/2024 10:43 AM EDT SeekingAlpha Psychedelic stocks mixed as FDA comments on MDMA therapy
Page